Skip to content

Clinical trials

Phase 1/2 Inflammation trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 1/2 Country / region: China Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20131
20171
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting2
Unknown status2
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hudson Biotech1
LI Taisheng1
Shanghai University of Traditional Chinese Medicine1
University of Illinois at Chicago1
Xuanwu Hospital, Beijing1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation5
Amyotrophic Lateral Sclerosis1
Atherosclerosis1
Autoimmune Diseases1
Cough-Variant Asthma1
Diabetes Mellitus, Type 21
Neurodegenerative Diseases1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.